Newsroom

worldwide offices | contact | help | sitemap

Media releases

22-Jan-2013

Novartis receives EU approval for Bexsero^®, first vaccine to prevent the leading cause of life-threatening meningitis across Europe

14-Jan-2013

Pivotal study in The Lancet shows potential of Novartis vaccine Bexsero^® to help provide broad protection to infants against MenB

20-Nov-2012

Novartis receives FDA approval for Flucelvax^®, the first cell-culture vaccine in US to help protect against seasonal influenza

16-Nov-2012

Novartis receives positive CHMP opinion for Bexsero^®, a groundbreaking vaccine to help prevent devastating MenB infections, the leading cause of meningitis in Europe

09-Nov-2012

Italian authorities lift precautionary hold on Novartis seasonal influenza vaccines

31-Oct-2012

Health Canada and Swissmedic lift precautionary holds on Novartis seasonal influenza vaccines

25-Oct-2012

Novartis confident in safety and efficacy of its seasonal influenza vaccines produced in Italy

26-Jul-2012

Novartis begins shipment of Fluvirin^® seasonal influenza vaccine in US for 2012-2013 influenza season

10-Feb-2012

FDA requests additional data on Novartis quadrivalent meningococcal conjugate vaccine, Menveo^®, for expanded use in infants

7-Feb-2012

Pivotal study published in JAMA confirms potential of Novartis candidate vaccine Bexsero^® to help protect infants against devastating meningococcal serogroup B disease

View all press releases

Feature stories ›

Read in-depth stories about how Novartis is addressing the changing needs of patients and societies worldwide.

fact sheet

Fact sheet ›

Read and download the Novartis fact sheet.

Multimedia library ›

Visit the Novartis multimedia library to view and download photos, images and videos.

Media contacts ›

Novartis Vaccines welcomes enquiries from the media. If you don't find the information you need here, please feel free to contact us directly with any questions you may have.

Disease & products

disease & products

Learn about meningitis, influenza, rabies, TBE and japanese encephalities.

Learn the diseases and the vaccines that prevent them

About Novartis Vaccines

vaccines

Novartis Vaccines is the world's fifth-largest vaccines business.

Learn about our mission, business and people

NOVZn

See stock performance

NVS

See stock performance